BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer products company, announced today that the Company has held a roundtable with German decision-makers to legalize the controlled sale of cannabis to adults initiated in Germany for pleasure purposes. At that meeting, German Drug Commissioner Burkhard Blienert presented the plan for the legalization of cannabis for adults and reiterated the German government’s announcement that a first draft law would be presented in the coming months. With this event, Tilray reaffirms its leading role as a trusted partner of the federal government and contributes to the German legalization effort by bringing to bear its many years of expertise and experience in the areas of cannabis research, product quality and safety, supply management, patient and consumer protection, and educational work .

Attendees at the meeting included senior figures from Germany’s health and legal committees, including:

• Burkhard Blienert, Drug Commissioner of the Federal Government in the Federal Ministry of Health
• Kristine Lütke, member of the Bundestag (FDP) and drug policy spokeswoman for the FDP
• Carlos Kasper, member of the Bundestag (SPD) and member of the finance committee
• Martina Stamm-Fibich, member of the Bundestag (SPD) and member of the health committee

Denise Faltischek, Head of Strategy and International at Tilray Brands, Inc. said, “We are honored to have initiated this high-level exchange on one of the most important cannabis ventures in the world. As a leading global cannabis company, Tilray Brands has unique experience in the Working with governments and regulators to ensure responsible regulation of…